Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as Chief Medical Officer
Position
Chief Medical Officer
Company
Damora Therapeutics, Inc.
WalthamBiotechnologyHealthcareHealth CareMedicalTherapeuticsDescription
Galecto, Inc announces the appointments of Sherwin Sattarzadeh as Chief Operating Officer and Dr Becker Hewes as Chief Medical Officer, effective January 5, 2026. Their extensive backgrounds in drug development are expected to strengthen the executive team as the company advances its clinical trials.
Quick answer
Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as Chief Medical Officer (January 6, 2026). Damora Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
- Who is the new Chief Medical Officer at Damora Therapeutics, Inc?
- Damora Therapeutics, Inc. named Becker Hewes Chief Medical Officer, announced January 6, 2026.
- What did Damora Therapeutics, Inc. announce on January 6, 2026?
- Galecto, Inc announces the appointments of Sherwin Sattarzadeh as Chief Operating Officer and Dr Becker Hewes as Chief Medical Officer, effective January 5, 2026. Their extensive backgrounds in drug development are expected to strengthen the executive team as the company advances its clinical trials.
- What does Damora Therapeutics, Inc. do?
- Galecto is a clinical-stage biotechnology company developing novel small-molecule therapeutics that target the core biological drivers of fibrosis, inflammation, and cancer.
- Where is Damora Therapeutics, Inc. based?
- Damora Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Aquestive Therapeutics, Inc. (February 18, 2026), NuCana (January 6, 2026), Fractyl Health (January 6, 2026) and Archeus Technologies (January 7, 2026) also announced leadership changes within 45 days of Damora Therapeutics, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Medical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aquestive Therapeutics Appoints Dr. Matthew Greenhawt as Chief Medical Officer (February 18, 2026)
- NuCana Appoints Theresa Bruce as Chief Operating Officer (January 6, 2026)
- Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer (January 6, 2026)
- Archeus Technologies Appoints Reinier Hernandez as Chief Technology Officer and Zachary Morris as Chief Medical Officer (January 7, 2026)
- BioMarin Appoints Arpit Davé as Chief Digital and Information Officer (January 12, 2026)
- Interwell Health Appoints Carney Taylor as Chief Medical Officer (January 26, 2026)
Who to call at Damora Therapeutics, Inc., and when
A new leader at Damora Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Damora Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Damora Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Damora Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Damora Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Damora Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.